Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science of addressing critical issues with CAR T cell therapy in patients with ...

The tool analyzes results from standard tests of organ function, tumor burden, and inflammation to predict whether lymphoma patients will respond to treatment.

Over the past 20 years our research has contributed to transforming the lives of patients with diseases of the blood, including non-Hodgkin lymphoma ... White blood cells, called T and B ...